Story
OpenAI Reportedly Seeks $30 Billion in Funding at $1.4 Trillion Valuation

Summary
The artificial intelligence leader is in early-stage talks for a massive new funding round that would solidify its position as one of the world's most valuable private companies, according to a Bloomberg News report.
OpenAI is in early discussions to raise at least $30 billion in a new funding round that would value the artificial intelligence pioneer at approximately $1.4 trillion before the new investment, Bloomberg News reported Tuesday, citing people familiar with the matter. The potential deal underscores intense investor appetite for leading AI firms and would represent a landmark valuation in the private markets.
Funding Details Emerge
The discussions are still in a preliminary phase and the final terms, including the size and valuation, could change, according to the report. Demand for the round is reportedly being led by investors eager to increase their exposure to the rapidly growing company.
The proposed capital injection is being framed as a form of bridge financing, providing the company with substantial capital as an alternative to an initial public offering (IPO). OpenAI did not immediately respond to a request for comment, Reuters noted.
Strategic and Financial Context
AdThis financing strategy aligns with public statements from CEO Sam Altman, who said earlier this month that the company would not pursue an IPO in 2026, citing safety concerns related to the advancement of artificial intelligence.
The potential $1.4 trillion valuation marks a significant step-up from the company's previous financing. In March, OpenAI closed a funding round with $122 billion in committed capital that valued the firm at $852 billion.
Soaring Revenue Growth
The soaring valuation is underpinned by the company's torrid revenue growth. A separate Reuters report on Tuesday indicated that OpenAI’s annualized revenue run rate is nearing $70 billion. This figure represents an increase of more than 70% since the beginning of the third quarter, highlighting the explosive commercial demand for its AI products and services.
Read next
More on Stocks
U.S. Stock Futures Edge Higher as Treasury Yields Retreat from 17-Year High
U.S. equity futures saw modest gains as a pullback in Treasury yields and a sharp drop in oil prices offered some relief to investors. Markets are now focused on upcoming inflation and jobs data for further clues on Federal Reserve policy.

Robinhood Unveils In-App AI Agents for Automated Retail Trading
Robinhood Markets announced the launch of 'Robinhood Agents,' a new feature allowing users to build and deploy AI-powered bots to automate trading strategies for stocks, options, and crypto directly on its platform.

Dyne Therapeutics Shares Rise on Positive 12-Month Data for DM1 Drug
The clinical-stage biotech company reported significant functional improvements in patients with myotonic dystrophy type 1 (DM1) in its Phase 1/2 ACHIEVE trial, boosting investor confidence.

Accelevation Prices IPO at $18 Per Share Ahead of Nasdaq Debut
Accelevation Holdings Corp. has priced its initial public offering of 30 million shares at $18.00 each, with the majority of shares being sold by existing stockholders. The company is set to begin trading on the Nasdaq under the ticker ACCV.